|4Aug 15, 4:15 PM ET

Banks Robert R. Jr. 4

4 · NEPHROS INC · Filed Aug 15, 2023

Insider Transaction Report

Form 4
Period: 2023-08-14
Banks Robert R. Jr.
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2023-08-14$1.50/sh+99$14999 total
  • Purchase

    Common Stock

    2023-08-15$1.69/sh+1,901$3,2072,000 total
Holdings
  • Stock Option (right to buy)

    Exercise: $1.44Exp: 2033-05-05Common Stock (357,165 underlying)
    357,165
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.66 to $1.73, inclusive. The reporting person undertakes to provide Nephros Inc., any security holder of Nephros Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the set range set forth in this footnote.
  • [F2]Options to purchase 89,291 shares vest on 5/5/24 and options to purchase 267,874 shares vest quarterly in 12 equal amounts commencing on 8/5/24.

Documents

2 files
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

  • EX-24